Distinct cytokine and chemokine patterns in chronic diabetic ulcers and acute wounds 1 | BACKGROUND
Wound healing is a central physiological process that restores the barrier properties of the skin after injury and infection. [1] Defective wound healing is a burden to millions of patients worldwide with diabetes mellitus being a major risk factor for chronic wounds. [2] Besides wound bed infections, especially neuropathy and angiopathy accompanied with decreased blood supply and excessive necrotic tissue are the major problems [3] resulting in a mislead inflammation that ultimately disturbs the sequence of events necessary for wound closure. [4] Inflammation is governed mainly by wound bed resident leucocytes and skin cells [5] as well as their intercellular communication which strongly depends on signalling molecules (cytokines and chemokines). [6] Non-healing wounds were shown to display an imbalance in these molecular signatures.
[7]
| QUESTION ADDRESSED
We hypothesized to find a chemokine/cytokine signature in human chronic diabetic wounds that extends to the molecules involved in the current picture of mislead inflammation in this pathology.
| EXPERIMENTAL DESIGN

| Sampling human wound material
Wound dressings of non-healing wounds of diabetic patients at the 
| Determination of cytokine and chemokine concentrations
The presence and quantity of 37 different cytokines and chemokines in solute wound material were assessed against known concentrations of analytes using bead-based multiplex as- 
| RESULTS
We here compared the secretory profiles of 37 molecules ascribing distinct cytokine and chemokine signatures to physiological and pathological wound healing ( Table 2 ). The presence and regulation of a number of prominent wound regulators such as IL-1β, IL-6, IL-8, IL-18, bFGF, EGF, VEGF and PDGF have also been reported in previous studies, [7] [8] [9] 10] suggesting our experimental approach to be valid. However, we could not identify an increase in TNF-α or TGF-α as previously seen in chronic wounds. [7, 11] Instead, we measured a strong decrease in TGF-α which was previously linked T A B L E 1 Description of the study cohort
Chronic diabetic Acute surgical
Number of patients 14 10
Patient age (years±SD) 65±9 58±16
Gender (m/w) 11/3 7/3
Wound age (days±SD) >180 13±12
to reduced keratinocytes and fibroblast influx.
[12] The concentra- IL-10 n.s.
negatively regulated RANTES expression, yet without positive consequences for wound healing. Also levels of I-TAC (CXCL11), a keratinocyte and endothelial cell-derived chemokine [19] functioning in an autocrine/paracrine fashion in wound repair, [20] were strongly downregulated in chronic wounds. This may reflect the diabetic wound not successfully transitioning to the proliferative phase as CXCL11-expressing cells are present at T-cell infiltrates in various human skin diseases, [21] suggesting a mislead inflammation that is also known to be detrimental in healing. IL-17 and IL-23 were shown to be important in distorted inflammation as well.
[22] Considering their parallel regulation, M1 macrophage-derived IL-23 drives inflammation via IL-17 and T H 17 induction [23] in many diseases, for example colitis and autoimmunity.
[24] Both molecules were decreased in chronic wounds, in line with the rather low-grade chronic inflammation seen in these conditions [25] compared to the stronger inflammatory profile in, for example, psoriasis.
[26] HGF is an antiscarring protein [27] and was decreased in diabetic wounds in our study. In a previous skin biopsy study, less HGF was found acute compared to chronic wounds.
[28] Another protein, erythropoietin (EPO), was decreased in diabetic wounds as well. Exogenous supplementation with this molecule has been suggested for therapy to enhance healing, [29] also in diabetic patients, [30] by increasing NO and VEGF release.
[31] IP-10
was also downregulated in chronic wounds. In normal wound healing, it parallels lymphocyte immigration, [13] serves a role in dermal remodelling, for example via inhibition of fibroblast migration, [20] and is angiostatic.
[32]
| CONCLUSION
The expression of 37 different cytokines and chemokines in acute and 
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